Edition:
United States

Array Biopharma Inc (ARRY.OQ)

ARRY.OQ on NASDAQ Stock Exchange Global Market

19.99USD
20 Jun 2018
Change (% chg)

-- (--)
Prev Close
$19.99
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
761,671
52-wk High
$20.17
52-wk Low
$7.15

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.19 June 21 Jun 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 4
(2) OUTPERFORM 5 5 5 5
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.62 1.62 1.62 1.56

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 2 46.23 46.96 45.50 --
Quarter Ending Mar-18 8 31.67 42.00 25.00 --
Year Ending Jun-18 8 174.52 200.00 157.53 114.91
Year Ending Jun-19 8 216.11 301.70 107.00 239.27
Earnings (per share)
Quarter Ending Dec-18 2 -0.19 -0.10 -0.29 --
Quarter Ending Mar-18 8 -0.23 -0.16 -0.33 --
Year Ending Jun-18 8 -0.74 -0.65 -0.85 -0.88
Year Ending Jun-19 8 -0.61 -0.22 -1.16 -0.32

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 31.67 66.37 34.70 109.59
Quarter Ending Dec-17 26.67 42.22 15.54 58.27
Quarter Ending Sep-17 33.28 29.75 3.53 10.61
Quarter Ending Jun-17 28.60 33.78 5.17 18.09
Quarter Ending Mar-17 36.99 33.28 3.71 10.04

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 46.23 46.23 46.23 35.48 --
Quarter Ending Mar-18 31.67 -- -- -- --
Year Ending Jun-18 174.52 174.52 174.52 136.88 114.91
Year Ending Jun-19 216.11 216.11 216.11 196.41 239.27

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-18 -- -- -- --
Year Ending Jun-18 0 0 0 0
Year Ending Jun-19 0 0 0 0
Earnings